New Zealand’s Pharmac Faces Down Roche Diagnostics On Diabetes Gear
This article was originally published in PharmAsia News
Executive Summary
New Zealand’s drug-purchasing agency reportedly accused Roche Diagnostics of launching a campaign against its proposal to award a $8.9 million diabetic-equipment contract to a single supplier.